Goldman et al., L-696,229 Specifically Inhibits Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Possesses Antiviral Activity In Vitro, Antimicrobial Agents Chemotherapy, pp. 1019-1023(1992). |
Grobelny, et al., Selecive Phosphinate Transiion-State Analogue Inhibitors of the Protease of Human Immunodeficiency Virus; Biochemical and Biophysical Research Communications; vol. 169, No. 3, pp. 1111-1116(1990). |
Hui, et al., A Rational Approach in the Search for Potent Inhibitors Against HIV proteinase; The FASEB Journal, vol.5, pp. 2606-2610(1991). |
Humber, et al., Penicillin Derived C.sub.2 -Symmetric Dimers as Novel Inhibitors of HIV-1 Proteinase, J. Med. Chem., 35, pp. 3080-3081 (1992). |
Ikeda, et al., .PSI.�PO.sub.2 -CH.sub.2 N.sup.+ !, a New Amide Bond Replacement: Potent Slow-Binding Inhibition of the HIV Protease, J. Am. Chem. Soc., 114, pp. 7604-7606 (1992). |
Kotler, et al., Synthetic Peptides as a Substrates and Inhibitors of a Retroviral Protease; Proc. Natl. Acad. Sci., vol. 85, pp. 4185-4189(1988). |
Kahn, et al., Examination of HIV-1 Protease Secondary Structure Specificity Using Conformationally Constrained Inhibitors; J. Med. Chem., , pp. 3395-3399(1991). |
Kempf, et al., Structure-Based, C.sub.2 Symmetric Inhibitors of HIV Protease; J. Med. Chem., 33, pp. 2687-2689(1990). |
Kempf, et al., Antiviral and Pharmacokinetic Properties of C.sub.2 Symmetric Inhibitors of the Human Immunodeficiency Virus Type 1 Protease; Antimicrobial Agents and Chemotherapy , vol. 35, No. 11, pp. 2209-2214(1991). |
Korant, et al., Virus-specified protease in poliovirus-infected HeLa cells; Proc. Natl. Acad. Sci. USA, vol. 76, No. 6, pp.2992-2995(1979). |
Krohn, et al., Novel Binding Mode of Highly Potent HIV-Proteinase Inhibitors Incorporating the (R)-Hydroxyethylamine Isostere; J. Med. Chem. 34, pp. 3340-3342(1991). |
Lambert, et al., Human Immunodeficiency Virus Type 1 Protease Inhibitors Irreversibly Block Infectivity of Purified Viriond from Chronically Infected Cels; Antimicrobial Agents and Chemotherapy, pp. 982-988(1992) (absract only). |
Lingham, et al., HIV-1 Protease Inhibitory Activity of L-694,746, A Novel Metabolite of L-689,502; Biochemical and Biophysical Research Comm., vol. 181, No. 3, pp. 1456-1461(1991). |
Lingham, et al., L-696,474, A Novel Cytochalasin as an Inhibitor of HIV-1 Protease III. Biological Activity; J. of Antibiotics, p. 686(1992). |
Lyle, et al, Benzocycloalkyl Amines as Novel C-Termini for HIV Protease Inhibitors; J. Med. Chem., 34, pp. 1228-1230(1991). |
McLeod, et al., Phosphonamidates and Phosphonamidate Esters as HIV-1 Protease Inhibitors; Bioorganic & Medicinal Chemistry Letters, vol. 1, No.11, pp. 653-658(1991). |
Mimoto, et al., KNI-102 A Novel Tripeptide HIV Protease Inhibitor Containing Allophenylnorstatine as a Transition-State Mimic; Chem. Pharm. Bull. vol. 39, No. 11, pp. 3088-3090(1991). |
Mimoto, et al., Rational Design and Synthesis of a Novel Class of Active Site-Targeted HIV Proease Inhibitors Containing a Hydroxymethylcarbonyl Isotere. Use of Phenylnorstatine or Allophenylnorstatine as a Transition-State Mimic; Chem. Pharm. Bull. vol. 39, No. 9, pp.2465-2467(1991). |
Moore, et al. Peptide Substrates and Inhibitors of the HIV-1 Protease; Biochemical and Biophysical Research Communications; vol. 159, No. 2, pp. 420-425(1989). |
Ondeyka, et al., L-696,474, A Novel Cytochalasin as an Inhibitor of HIV-1 Protease II. Isolation and Structure; J. of Antibiotics, vol. 45, No. 5, p.679(1992). |
Owens, et al., The Rapid Identification of HIV Protease Inhibitors Through the Synthesis and Screening of Defined Peptide Mixtures; Biochemical and Biophysical Research Communications; vol. 181, No. 1 pp. 402-408 (1991). |
Peyman, et al., C.sub.2 -Symmetric Phosphinic Acid Inhibitors of HIV Protease; Tetrahedron Letters, vol. 33, No. 32, pp. 4549-4552(1992). |
Raju, et al., Substrate Analog Inhibitors of HIV-1 Protease Containing Phenylnorstatine as a Transition State Element; Biochemical and Biophysical Research Communications; vol. 180, No. 1, pp. 181-186(1991). |
Raju, et al., Investigating the Stereochemistry of Binding to HIV-1 Protease with Inhibitors Containing Isomers of 4-Amino-3-hydroxy-5-phenylpentanoic Acid,, Biochemical and Biophysical Research Communications, vol. 180, No. 1, pp. 187-190(1991). |
Rich, et al., Hydroxyethamine Analogues of the p17/p24 Substrate Cleavage Site Are Tight-Binding Inhibitors of HIV Protease; J. Med. Chem., 33, pp. 1285 -1288. (1990). |
Rich, et al., Effect of Hydroxyl Group Configuraton in Hydroxyethylamine Dipeptide Isosteres on HIV Protease Inhibition. Evidence for Multiple Binding Modes; J. Med. Chem., 34, pp. 1222 -1225 (1991). |
Roberts, et al., Rational Design of Peptide -Based HIV Proteinase Inhibitors; Science, vol. 248, pp. 358 -361 (1990). |
Schramm, et al., Inhibition of HIV-1 Protease By Short Peptides Derived From the Terminal Segments of the Protease; Biochemical and Biophysical Research Comm., vol. 184, No. 2, pp. 980 -985 (1992). |
Sham, et al., Potent HIV-1 Protease Inhibitors with Antiviral Activities In Vitro; Biochemical and Biophysical Research Communications; vol. 175, No. 3, pp. 914 -919 (1991). |
Tam, et al., Intriguing Structure-Activity Relations Underlie the Potent Inhibition of HIV Protease by Norstatine-Based Peptides; J. of Medicinal Chemistry, vol. 35, No. 7, pp. 1318 -1320 (1992). |
Thaisirivongs, et al., Inhibitors of the Protease from Human Immunodeficiency Virus: Design and Modeling of a Compound Containing a Dihydroxyethelene Isostere Insert with High Binding Affinity and Effective Antiviral Activity; J. Med. Chem., 34, pp. 2344-2356 (1991). |
Thompson, et al., Synthesis and Antiviral Activit of a Series of HIV-1 Protease Inhibitors with Functionality Tethered to the P.sub.1 or P.sub.1 'Phenyl Substituents: X-ray Crystal Structure Assisted Design; J. Med. Chem., 35, pp. 1685 -1701 (1992). |
Tomaselli, et al., Specificity and Inhibition of Proteases from Human Immunodeficiency Viruses 1 and 2; The Journal of Biochemical Chemistry vol. 265, pp. 14675-14683 (1990). |
Tucker, et al., A. Series of Potent HIV-1 Protease Inhibitors Containing a Hydroxyethyl Secondary Amine Transition State Isotere: Synthesis, Enzyme Inhibition, and Antiviral Activity, J. Med. Chem., 35, 2525-2533 (1992). |
Urban, et al., Reduced-bond Tight-Binding Inhibitors of HIV-1 Protease, Fine Tuning of the Subsite Specificity; FEBS Letters, vol.298, No. 1, pp. 9 -13 (1992). |
Vacca, et al., L-687,908, a Potent Hydroxyethylene-Containing HIV Protease Inhibitor; J. Med. Chem., 34, pp. 1225 -1228 (1991). |
Young, et al., HIV-1 Potease Inhibitors Based on Hydroxythylene Dipeptide Isosteres: An Investigation into the Role of the P.sub.1 'Side Chain on Structure-Activity; J. Med. Chem., 35, pp. 1702 -1709 (1992). |
Ghosh, et al., 3-Tetrahydrofuran and Pyran Urethanes as High-Affinity P.sub.2 --Ligands for HIV-1 Protease Inhibitors, J. Med. Chem., 36, 292-294 (1993). |
Getman et al., Discovery of a Novel Class of Potent HIV-1 Protease Inhibitors Containing the (R)-(Hydroxyethyl)urea Isostere, J. Med. Chem., 36, 288-291 (1993). |
Ghosh et al., Cyclic Sulfolanes as Novel and High Affinity P.sub.2 -Ligands for HIV-1 Protease Inhibitors, J. Med. Chem., 36, 924-927 (1993). |
Martin, Antiviral. Res., 17, 265-278 (1992). |
Gordon et al., Biochem. Biophys. Res. Commun., 126(1), 419-426 (1985). |
Richards et al., FEBS Letters, 247(9), 113-117 (1989). |
Barrish et al., J. Med. Chem., 37, 1758-1768 (1994). |
CA95:102820: Bechtold et al., "Antiviral Properites of Aminodiol Inhibitors against Human Immunodeficiency Virus and Protease ", Antimicrobial Agents and Chemotherapy, pp. 374-379 (Feb. 1995). |
CA94:281338: Barrish et al., "Novel Aminoalcohol Inhibitors of HIV Protease: Design, Synthesis, and Characterization ", Aniviral Research 23( Supp. 1 ), Seventh International Conference on Antiviral Research, Charleston S.C. (Feb. 27 -Mar. 4, 1994). |
CA94:281361: Ahmad et al., "Potent Inhibitors of HIV Protease: P.sub.2 and P.sub.3 Extended Analogs of BMS-182, 193", Antiviral Research 23 (Supp. 1), Seventh International Conference on Antiviral Research, Charleston S.C. (Feb. 27 -Mar. 4, 1994). |
CA94:281360: Bisacchi et al., "Systematic SAR Studies of BMS-182, 193, A Novel Inhibitor of HIV Protease", Antiviral Research 23 (Supp. 1), Seventh International Conference on Antiviral Research, Charleston, S.C. (Feb. 27 -Mar. 4, 1994). |
CA94:281344: Bechtold et al., "Antiviral Properties of BMS 182, 193, an Aminoalcohol Inhibitor of HIV Protease", Antiviral Research 23 (Supp. 1), Seventh International Conference on Antiviral Research, Charleston, S.C. (Feb 27 -Mar. 4, 1994). |
CA94:281338: Barrish et al., "Novel Aminoalcohol Inhibitors of HIV Protease: Design, Synthesis, and Characterization", Antiviral Research 23 (Supp. 1), Seventh International Conference on Antiviral Research, Charleston, S.C. (Feb. 27 -Mar. 4, 1994). |
CA94:361189: Wlodawer, "Rational Drug Design: The Proteinase Inhibitors", Pharmacotherapy, 14/6 II, p. 9S-20S (1994). |
CA94:463934: Tino et al., "Novel Aminodiol Inhibitors of HIV Protease. Design, Synthesis, and Characterization", Abstracts of Papers American Chemical Society 208 (1-2) (1994) for 208th National Meeting of the American Chemical Society, Washington, D.C. (Aug. 21 -25, (1994). |
March, J., "Advanced Organic Chemistry"1985, J. Wiley & Sons, New York, pp. 270, 664, 726 and 727. |
Eds. L. Kaudy, J. F. Rounsaville, G. Schultz: "Ullmann 's Encyclopedia of Industrial Chemistry, 5th Edition", 1987, VCH, Weinheim, pp. 531-545. |